3rd Pakistan Pharma Summit | 3rd Pakistan Pharma Summit
About PPMA
Founded in 1961, the PPMA is recognized by the government of Pakistan as the only representative Pharma body in the country which has about 400 members which comprises both national and multinational companies. Pakistan Pharma Industry is very vibrant and dynamic comprising more than 700 units, currently fulfilling more than 95% of the domestic Pharmaceutical requirements. One of the goals is to ensure availability of quality medicines to all at reasonable price and to enhance exports of the country by accessing more value added markets of Europe and USA.
Key Topics
  • Alignment with Global Landscape - A Futuristic Approach
  • New Emerging Therapeutics and Regulatory Imperatives
  • CEO Panel: Reshaping Pakistan‘s Pharmaceutical Industry: Challenges & Opportunities
  • Creating Health Awareness: Role of Pharmaceutical Industry of Pakistan
  • Phytopharmaceuticals – Innovation | Quality | Regulatory
  • Igniting Digital Pharma
  • Regulatory Guidelines – Present and future scenario
  • Pharmaceutical Serialization – track and trace system
Message from Organizers

The crossroads that Pharma industry finds itself at can be summed up in the opening lines of the Charles Dicken‘s novel, A Tale OF Two Cities, "It was the best of times, it was the worst of times".

The Future looks promising yet laced with perils. As human intellect dynamically evolves & knowledge of things improve by leaps and bounds our scientific base is also expanding proportionally. Lengthening human life expectancy has increased the demand for medicines (global Pharma market expected to reach $ 1.12 Trillion by 2022) & advances in genetic& genomics has tectonically shifted the balance. Technology has taken the game to the next level.

New emerging therapeutics create a sweet spot where biology & technology converge to open new opportunities. From precision medicine that provides the biological basis of disease to mHealth sensors targeting Parkinson‘s disease, diabetes, cardiovascular disease, asthma and breast cancer to Spritam ,first 3-D FDA approved printed drug for epilepsy, the quantum leap is unbelievable.

3rd Pharma summit draws exceptional brains in a quest to write answers to these challenging questions that life throws at us at lightning speed. The event also provides one of the rare opportunities to deepen our insight & expand our knowledge to ensure a brighter future. The Summit also features panel discussions & success stories for a profound learning experience. We look forward to your gracious presence to make it an unforgettable experience of your life.


Prof. Dr. Sarfaraz K. Niazi (USA)
  • Most Interesting Man Revolutionizing The Health World‘s Forbes 2014
  • Biosimilars Pioneer, Inventor, Teacher and Author
  • Founder, Therapeutic Proteins, a Biosimilars Company, USA
  • Adjunct Professor, University of Illinois, Chicago
  • Sitara-e-Imtiaz
Dr. René Roth-Ehrang (Germany)
  • Board Member of Finzelberg (Business unit of Martin Bauer Group)
  • Director, European Technical Services, Amway
  • Ex-European Director Regulatory Affairs, Quality Assurance & Product
  • Development Liaison, Access Business Group

Dr. Muhammad Aslam

CEO, Drug Regulatory Authority of Pakistan (DRAP)

Dr. Kaiser Waheed

Chairman, PPMA and Managing Director, Medisure

Haroon Qassim

Chairman of 3rd Pakistan Pharma Summit and MD & CEO, PharmEvo

M. Jawed Akhai

Chairman, Martin Dow

Syed Nadeem Ahmed

Chief Executive Officer, The Searle Company Limited

Dr. Shahzad Khan

Chief Operating Officer, CCL Pharmaceuticals

Zahid Saeed

Managing Director, Indus Pharma

Mian M. Zaka Ur Rehman

CEO, Schazoo Zaka

Anis A. Shah

MD & CEO, Merck

Adnan Rizvi

Partner & Head of Deal Advisory, KPMG Taseer Hadi & Co.

Khawaja Shahzeb Akram

Vice President, Mass Pharma

Dr. Ajmal Nasir

Director Technical, BF Bisciences(a subsidiary of Ferozsons Group)

Mian Asad Shuja-ur-Rehman

Chief Executive, Schazoo SPLa

Dr. Riaz Ahmed

CEO, Shrooq Pharma

Zeba Ahmed Shuja

Director Technical, Schazoo Zaka

Ch. M. Israr Sharif

Managing Director, Genix Pharma Pvt Ltd

Furqan Kidwai

CEO, Dawai.pk

Arshad Rahim Khan

Managing Director, OBS Pakistan (Pvt.) Ltd.

Dr. Rizwan Mahmood

Director Quality Ops, CCL Pharmaceuticals

Abdul Latif Sheikh

President and CEO, Pakistan Society of Health System Pharmacist (PSHP)

Hamid Raza

CEO, Neutro Pharma

Dr Muzna Ebrahim

TV Anchor & Chairman of patient advocacy group ‚The U within Association′

(Master of Ceremonies)

Post Conference Masterclass


Shifting priorities and the way forward for Pakistan

by Prof. Dr. Sarfaraz K. Niazi
CEOs, Directors, Presidents/ Vice Presidents, General Managers/ Managers & Business Intelligence experts in pharmaceutical, biologics, and OTC drugs and medical device companies involved in:
  • Marketing
  • Marketing Communications
  • Legal, Regulatory Affairs
  • Public Relations/Corporate Affairs
  • Medical Information and Affairs
  • Compliance
Tuesday, 25 July 2017 | 10:00 am - 02:00 pm
Gold Sponsors
Silver Sponsor
Bronze Sponsor
Tea Sponsor
Conference Producer
Conference Registration Fee
Rs. 6,000 Per participant
24th July 2017
Workshop Registration Fee
Rs. 8,000 Per participant
25th July 2017
Gold Pass (Conference+Workshop)
Rs. 12,000 Per participant
24th - 25th July 2017
Includes Lunch, Refreshments & Business Networking
For further details, please contact
Talha Shabbir - General Manager Conference Division, TerraBiz
Mobile: +92 321 8747 595 | Tel: +92 21 3455 6975
Email: pharmasummit@terrabizgroup.com
For Exhibition, please contact
Zakir Adil - Assistant Secretary, PPMA
Mobile: +92 300 2278 183